BNET Industries
Market Cap:$17.5M
Last Fiscal Year Sales:$11.3M
- Public
- US
Dow Jones Description
Cyanotech develops and commercializes natural products from microalgae. The Company is currently producing microalgae products for the nutritional supplement and immunological diagnostics markets in addition to microalgae-based products for the aquaculture feed/pigments and food coloring markets. Microalgae are a diverse group of over 30,000 species of microscopic plants which have a wide range of physiological and biochemical characteristics and naturally contain high levels of nutrients. Microalgae represent a largely unexplored and unexploited renewable natural resource, which grow much faster than land-based plants. Under favorable growing conditions, certain microalgae produce a new crop every week. Cyanotech has designed, developed and implemented proprietary production and harvesting technologies, systems, and processes that eliminate many of the stability and contamination problems frequently encountered in the production of microalgae. The Company's technologies, systems, processes and favorable growing location permit year-round harvesting of its microalgae products in a cost-effective manner. Cyanotech maintains an environmentally responsible philosophy in the development and production of its products, using natural production methods and resources that employ extensive recycling of raw materials and nutrients. The Company believes that these recycling methods result in substantially lower operating costs. ...
President & CEO
Andrew H. JacobsonNumber of Employees 63
Contact Information
73-4460 Queen Kaahumanu Hwy Ste 102
Kailua Kona, Hawaii 96740
(808) 326-1353
Peer Companies
NAICS Code Medicinal and Botanical Manufacturing: 325411
Recent Events
-
Cyanotech Reports FY10 Q2 Results
-
BRIEF: Cyanotech earnings jump more than 50% as sales surge
-
Cyanotech has impressive turnaround for the year
News & Analysis
Filter by
cyanotech corp. - All News and Analysis
Cyanotech Corp. Achieves Nasdaq Compliance.
M2 PRESSWIRE-16 March 2007-International Stock Targets: Cyanotech Corp. Achieves Nasdaq ComplianceC1994-2007 M2 COMMUNICATIONS LTD RDATE:16032007 Cyanotech Corp. (Nasdaq:CYAN) was down 2.95 today on just over 12,000 shares traded. Cyanotech Corporation, which makes algae-based nutritional products, said today it...
Cyanotech Corporation Announces Results of Independent Laboratory Testing of Spirulina
KAILUA KONA, Hawaii -- Cyanotech Corporation (Nasdaq:CYAN) a world leader in producing high-value natural products from microalgae, today announced the results of testing done at the Department of Biological Sciences at Wright State University (Dayton, Ohio), on Spirulina Pacifica confirming the absence of BMAA. An article, "Diverse taxa of...
Cyanotech Corporation Provides Update on Nasdaq Delisting Notification
Business Editors/Health/Medical Writers KAILUA KONA, Hawaii--BUSINESS WIRE--Nov. 14, 2003 Cyanotech Corporation (Nasdaq: CYAN), a world leader in producing high-value natural products from microalgae, today provided an update on the delisting notification by the Nasdaq Listing Qualifications Panel ("Panel"). In response to the Company's appeal to the Panel, Cyanotech...
Cyanotech Common Stock Moves to Nasdaq SmallCap Market
Business Editors KAILUA-KONA, Hawaii--BUSINESS WIRE--Sept. 20, 2002 Cyanotech Corporation (Nasdaq: CYAN) today announced that Nasdaq approved its application to transfer its common stock from the Nasdaq National Market System to the Nasdaq SmallCap Market effective September 23, 2002. Cyanotech's common stock will continue trading under its current...
Cyanotech Reports Fourth Quarter and Fiscal 2002 Financial Results; Maturity Date of Convertible Debentures Extended
Business Editors & Health/Medical Writers KAILUA-KONA, Hawaii--BW HealthWire--May 15, 2002 Cyanotech Corporation (Nasdaq NMS: CYAN), the world leader in producing high-value natural products from microalgae, today announced financial results for the fourth quarter and fiscal year ended March 31, 2002, and the extension of the maturity date on...
Cyanotech Becomes First Hawaii Industry Partner in MarBEC
KAILUA-KONA, Hawaii--BUSINESS WIRE--June 30, 1999-- University of Hawai'i President Kenneth P. Mortimer today welcomed Cyanotech Corporation (Nasdaq NMS:CYAN) as the first Hawai'i business to join the Marine Bioproducts Engineering Center MarBEC Industry Partner Program IPP. Mortimer was joined by Gerald R. Cysewski, Ph.D., president and chief executive officer...
Cyanotech increases bank line of credit to $2 million
KAILUA-KONA, Hawaii--BUSINESS WIRE--March 18, 1997--Cyanotech Corp. (NASDAQ/NMS:CYAN) Tuesday announced an increase in its bank line of credit with First Hawaiian Bank from $1 million to $2 million. "The increased credit facility, along with the company's cash position and strong cash flow from operations, will enable Cyanotech to...
Cyanotech Corp. announces ISO 9002 certification
KAILUA-KONA, Hawaii--BUSINESS WIRE--Sept. 20, 1996--Cyanotech Corp. (Nasdaq NMS:CYAN) announced at its annual meeting of stockholders in Honolulu yesterday that it has registered its quality system to ISO 9002:1994 standards, making it the first microalgae company, and the first company in Hawaii, to do so.ISO 9002 provides internationally recognized quality assurance...
Cyanotech to end participation in beta carotene joint venture
KAILUA-KONA, Hawaii--BUSINESS WIRE--July 25, 1996--Cyanotech Corp. (NASDAQ/NMS:CYAN) announced that it was ending its participation in the BetaPharm International joint venture project between itself and Hauser Chemical Research ("Hauser") Inc., Boulder, Colo.BetaPharm International was formed in 1994 as a joint venture between the two companies to develop, produce, and market natural...
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Andrew H. Jacobson | President & CEO |
| Deanna L. Spooner | CFO, Treasurer, Secretary, Vice President, Finance & Admin |
| Gerald R. Cysewski | Executive Vice President, Microalgae Product Dev & Chief Scientific Officer |
| Glenn Jensen | Chief Operating Officer |
| Bob Capelli | Vice President Sales |
| Marc G. Ketchel | Director, Sales |
| Gerald Cysewki | |
| David I. Rosenthal | Director |
| John T. Waldron | Director |
| Michael A. Davis | Director |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Gregg W. Robertson | Chairman |
| David I Rosenthaldenver | Board of Directors |
Andrew Jacobson joined Cyanotech as president and chief executive officer in May 2008. Mr. Jacobson has more than 23 years of experience in the natural products industry. He was president of the Personal Care division of the Hain Celestial Group. Hain is a leading natural and organic food and personal care products company with annual sales of approximately $1 billion. Previously at Hain, he was president of Natural Products. Mr. Jacobson joined Hain in 1997 through its acquisition of Westbrae Natural Foods where he was president.
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | President & CEO | Current |
| Cyanotech Corporation | Board of Directors | Current |
| The Hain Celestial Group, Inc. | President | Former |
| Natural Products Ltd | President | Former |
| The Hain Celestial Group, Inc. | Managing Director, Hain Celestial Canada, ULC | Former |
| The Hain Company | Former |
Ms. Spooner joined Cyanotech as Controller in January 2008. Previously, she worked in Hawaii as a financial consultant to varied commercial enterprises; as CFO and COO of ADcom Information Services of Deerfield Beach FL; as CFO and VP Administration of Hygeia Pharmaceuticals of San Diego CA; as Manager of Accounting and SEC Reporting at Oak Industries of Rancho Bernardo CA; and with Deloitte, Haskins & Sells, Audit Department in San Diego CA and Seattle WA.
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | CFO, Treasurer, Secretary, Vice President, Finance & Admin | Current |
| Organization | Position | Status |
|---|---|---|
| Nutrex, Inc. | CEO | Current |
| Cyanotech Corporation | Executive Vice President, Microalgae Product Dev & Chief Scientific Officer | Current |
| Cyanotech Corporation | Board of Directors | Current |
| Cyanotech Corporation | Chairman of the Board, President and Chief Executive Officer | Former |
| University of California, Santa Barbara | Assistant Professor | Former |
| University of California, Berkeley | Doctorate In Chemical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | Chief Operating Officer | Current |
| Cyanotech Corporation | Vice President Operations | Former |
| Cyanotech Corporation | Process Manager | Former |
| California State University | B.S. Degree In Health Science | Former |
Mr. Capelli has served as Vice President - Sales since March 2002. He joined Cyanotech in January 2002 as Director of Sales. Prior to joining Cyanotech, Mr. Capelli was Senior Sales Manager for Forcite-The Source, a division of Tree of Life, Inc. Mr. Capelli holds a B.A. degree from Rutgers University.
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | Vice President Sales | Current |
| Nutrex, Inc. | Vice President, Sales | Current |
| Cyanotech Corporation | Director of Sales | Current |
| Rutgers University | B.A. Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | Director, Sales | Current |
Cyanotech marketed at the Natural Products Expo West trade show in March 2006 at the Anaheim Convention Center in California. Bob Capelli introduced Cyanotech's founder and CEO, Dr. Gerald Cysewski, for a standing-room only seminar. Agnes Prehn talked with prospective customers at the company's booth in the exhibit hall.
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | Current |
Mr. Robertson was appointed to the Board of Directors of the Company in August 2004. Mr. Robertson is the President and Chief Executive Officer of Robertson & Company, a privately-owned investment banking firm which was established in 1986 and is currently based in Honolulu. Prior to establishing this firm, Mr. Robertson was the President and Chief Executive Officer of Dillingham Industries, Inc., a subsidiary of Dillingham Corporation. Previously Mr. Robertson held the positions of Executive Vice President and Chief Financial Officer of Dillingham Corporation. Mr. Robertson holds a B.S. degree in Economics from Fairleigh Dickenson University, Teaneck, N.J.
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | Chairman | Current |
| Cyanotech Corporation | President and Chief Executive Officer of Robertson & Company (Financial Services Consultancy) | Former |
| Cyanotech Corporation | Lead Independent Director | Former |
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Sanz, Inc. | Chief Financial Officer | Current |
| SpectraLink Corporation | CFO, Vice President, Finance & Admin & Secretary | Current |
| SpectraLink Corporation | Board of Directors | Current |
| Cyanotech Corporation | Director | Current |
| Celestial Seasonings, Inc. | Acting Chief Financial Officer | Former |
| StarTek, Inc. | CFO | Former |
| Cyanotech Corporation | Chairman | Former |
| California State University | MBA Degree | Former |
| University of California, Berkeley | Bachelor of Science Degree In Accounting | Former |
Mr. Waldron was appointed to the Board of Directors of the Company in July 1998. Mr. Waldron is CEO of Stratmark Services in Deerfield, Illinois and Adjunct Professor of Marketing at the Lake Forest Graduate School of Management in Lake Forest, Illinois. From 1986 to 1999, Mr. Waldron was Vice President-Sales and Marketing, Senior Vice President-Sales and Marketing, and Executive Vice President for Takeda U.S.A. Inc., a bulk vitamin and fine chemical products manufacturer. Mr. Waldron was also a Director of Takeda U.S.A. from 1993 to 1999, and served as a member of its Executive Committee and Compensation Committee. Mr. Waldron holds a Master of Management degree from Northwestern University's J. L. Kellogg Graduate School of Management.
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | Director | Current |
| Cyanotech Corporation | Chairman | Former |
Mr. Davis was appointed to the Board of Directors of the Company in March 2003 subsequent to his acquisition of $1,250,000 of subordinated convertible debentures of the Company in September 2002. Mr. Davis is a Principal at Ebb and Flow Ventures, a private equity firm; President of Skywords Family Foundation and a Director of Canobie Films, Inc. Mr. Davis attended Harvard University.
| Organization | Position | Status |
|---|---|---|
| Cyanotech Corporation | Director | Current |
Executive News
-
BRIEF: Cyanotech earnings jump more than 50% as sales surge
-
Cyanotech sees record revenue; stock jumps
-
Cyanotech sees record revenue; stock jumps
-
Cyanotech Reports FY10 Q1 Results
-
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2010 -- Record Revenues Exceed $4,000,000 and Profits Surge by 52% --
-
Cyanotech Reports Financial Results for the First Quarter of
-
Cyanotech Reports Financial Results for the First Quarter of Fiscal 2010
Industry Transcripts by Seeking Alpha
-
Avanir Pharmaceuticals F4Q09 (Qtr End 09/30/2009) Earnings Call Transcript
on Nov 24, 2009about AVNR
-
Palatin Technologies F1Q10 (Qtr End 9/30/09) Earnings Call Transcript
on Nov 16, 2009about PTN
-
Flamel Technologies SA Q3 2009 Earnings Call Transcript
on Nov 16, 2009about FLML
-
NexMed Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about NEXM
-
InterMune, Inc. Q3 2009 Earnings Call Transcript
on Nov 10, 2009about ITMN
IndustryTop Rated
- How NOT to Write a Biotech Press Release: Just Ask Epeius 5 votes
- More Tysabri Problems; Time for a Biogen-Idec Credibility Check 3 votes
- Fired Whistleblower Reps Make Similar Claim: Pfizer Said They Lacked "Integrity" 3 votes
- Biogen Idec's Social Media Ties Save Tysabri Again; FDA Watching 3 votes
- VeriChip TV Ad Confirms Critics' Fears: They Want Everyone Implanted 3 votes

